Cyclooxygenase-2 inhibitors: promise or peril?
The discovery of two isoforms of the cyclooxygenase enzyme, COX-1 and COX-2, and the development of COX-2-specific inhibitors as anti-inflammatories and analgesics have offered great promise that the therapeutic benefits of NSAIDs could be optimized through inhibition of COX-2, while minimizing thei...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
2002
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781678/ |